Literature DB >> 9051252

Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion.

M Yazaki1, M Andoh, T Ito, T Ohno, Y Wada.   

Abstract

Donor leukocyte infusion (DLI) was carried out on a 12-year-old girl with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who received allogeneic bone marrow transplantation from an HLA-identical sibling. This is the first report of DLI use before the onset of hematological relapse monitored by the results of RT-PCR. This patient has been in CR for 11 months after BMT, suggesting this alternative treatment is promising for Ph+ ALL with positive reverse transcriptase-polymerase chain reaction (RT-PCR) following BMT.

Entities:  

Mesh：

Year:  1997        PMID： 9051252     DOI： 10.1038/sj.bmt.1700663

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  6 in total

1.  Successful eradication of residual bcr-abl-positive clones by donor leukocyte transfusion in a patient with philadelphia chromosome-positive acute lymphoblastic leukemia after peripheral blood stem cell transplantation.

Authors:  T Tabayashi; K Masuda; K Yamada; M Takeuchi; K Matsue
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

2.  Successful treatment of minimal residual disease-positive Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib followed by reduced-intensity unrelated cord blood transplantation after allogeneic peripheral blood stem cell transplantation.

Authors:  Akiyoshi Takami; Shigeru Shimadoi; Chiharu Sugimori; Kenichi Takemoto; Masami Shibayama; Tomotaka Yoshida; Tohru Murayama; Kenichi Nagai; Koichi Miyamura; Hidesaku Asakura; Shinji Nakao
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

3.  Philadelphia chromosome-positive acute lymphoblastic leukemia rescued with a second allogeneic stem cell transplantation from a haploidentical mother after relapse following cord blood transplantation.

Authors:  Tatsuyuki Kai; Hideo Kimura; Yutaka Shiga; Shin Mineishi; Satoshi Yoshihara; Hiroyasu Ogawa; Etsuko Maruya; Hiroh Saji; Hitoshi Ohto; Yukio Maruyama
Journal:  Int J Hematol       Date:  2004-12       Impact factor: 2.490

Review 4.  Twenty years' experience in allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in the Nagoya Blood and Marrow Transplantation Group.

Authors:  Hiroatsu Iida; Hiroshi Sao; Kenjiro Kitaori; Seiichi Gotoh; Makoto Yazaki; Seiji Kojima; Atsushi Wakita; Yasuo Morishima; Yoshihisa Kodera; Yoshihisa Morishita
Journal:  Int J Hematol       Date:  2004-01       Impact factor: 2.490

Review 5.  Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  A K Fielding; G A Zakout
Journal:  Curr Hematol Malig Rep       Date:  2013-06       Impact factor: 3.952

Review 6.  Cellular therapies in acute lymphoblastic leukemia.

Authors:  Renier J Brentjens
Journal:  Curr Opin Mol Ther       Date:  2009-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.